IL1B and colorectal cancer: In other colorectal cancer cells, SW48 cells, EM treatment slightly decreased TNFα-stimulated or IL-1β-stimulated NF-κB promoter transcriptional activities in a dose-dependent manner (Fig. 1E and F).